A new synthetic method of 2,5-disubstituted pyrrolidines is developed by the cyclization of unsaturated N-benzoyloxysulfonamides by (CuOTf)2·C6H6 in refluxing dichloroethane. oxysulfonamides are cyclized to give pyrrolidines. The cyclization proceeds via addition of sulfonamidoyl radicals to intramolecular unsaturated bonds or allylic hydrogen abstraction with the radical intermediates.
Introduction
Pyrrolidines and other related azaheterocycles have attracted considerable interest due to their potential pharmacological activities, 1 and many synthetic methods have been developed. 2 Especially, intramolecular addition of nitrogen-centered radical onto unsaturated bonds is an attractive method to form fivemembered azaheterocycles.
3 Although halogenated amines have been commonly employed as N-radical precursors, they are too unstable to be widely applied in organic synthesis. 4 Hydroxylamine derivatives are used as alternative N-radical precursors such as amidyl, iminyl and aminyl radicals. 5 For example, Zard has employed a cascade radical cyclization starting from N-benzyloxyamides to construct the core of (±)-aspidospermidine.
turated O-acetyloximes were converted to dihydropyrroles in the presence of a catalytic amount of 1,5-naphthalenediol or CuBr·SMe2 via radical cyclization. 9 Therefore, it was expected that N-benzoyloxymethanesulfonamide 1a would also undergo radical cyclization under the above conditions. We chose N-benzoyloxymethanesulfonamide 1a as a model substrate for preliminary investigations (Table 1) .
In the initial experiments, the expected radical cyclization reaction did not take place at all with organic catalysts such as 1,5-naphthalenediol in dioxane at 100 o C. 10 Although the radical cyclization proceeded when 1a was treated with an equimolar amount of CuBr·SMe 2 in dioxane at 100 o C, the reaction proceeded very slowly and pyrrolidine 2a was isolated after 36 h only in 20% yield together with 65% recovery of the starting material ( (CuOTf)2·C6H6 was found to be effective, and the starting material 1a disappeared in 5 h, yielding 2a in 37% yield (Table  1 , entry 3). In contrast, performing the reaction in toluene or 1,2-dichloroethane gave 2a in markedly higher yields of 74% and 91%, respectively (Table 1 , entry 4 and 5). The radical cyclization of 1a proceeded smoothly when the reaction was carried out with a 5 mol % amount of (CuOTf)2·C6H6 in refluxing 1,2-dichloroethane to afford pyrrolidine 2a in 95% yield. In this reaction, 2a was obtained as a mixture of two stereoisomers with a 1:1 cis : trans ratio (Table 1 , entry 6, Determination of cis and trans stereochemistry of 2a, vide infra). It was afraid that TfOH generated by the hydrolysis of (CuOTf)2·C6H6 acted as an acid catalyst to cause the nucleophilic substitution reaction at the nitrogen atom. Hence, 1a was treated with a trace amount of TfOH in refluxing 1,2-dichloroethane, however the reaction did not proceed at all, and the use of an equimolar amount of TfOH made the reaction messy without formation of 2a.
A proposed mechanism of the formation of 2a by (CuOTf)2· C 6 H 6 -catalyzed reaction is depicted in Scheme 1. One-electron transfer from (CuOTf)2·C6H6 to 1a or oxidative addition of 1a occurs to generate intermediates A or B, and the resulting radical C cyclizes to generate alkyl radical D. Subsequently, the resulting copper(II) species oxidize the radical D to afford cation E with the regeneration of copper(I) complex. Finally, the elimination of a proton from intermediate E affords pyrrolidine 2a.
(CuOTf)2·C6H6-catalyzed cyclization of N-4-alkenyl-N-benzoyloxysulfonamides. With the optimized conditions in hand, the preparations of pyrrolidines 2 from various N-benzoyloxyamides 1 were examined as shown in Table 2 . Significant difference was not observed by replacement of benzoyloxy group to acetoxy group (entry 1 and 2), while methylsulfonyl group was found to be suitable as compared with arylsulfonyl groups, affording the product in a better yield (Table 2, entry 5, 6, 7, 8) . A lower catalyst loading a 0.02 molar amount of (CuOTf)2·C6H6 was sufficient for the cyclization of methylsulfonyl derivative 1e (Table 2, entry 5). Sulfonamides bearing a trisubstituted alkene moiety such as 1a ( Table 2 , entry 1) gave a higher yield of the product 2a as compared with the substrate bearing a disubstituted alkene moiety (Table 2, entry 4). Under the same conditions, 2a was obtained in 95% yield from 1a, whereas the yield of 2d was 56%. The trans configuration of trans-2d was confirmed by X-ray crystal determination as shown in Figure 1 . The significant difference of the trans and cis isomers appeared in 1 H NMR spectra. The 3-and 4-protons of the trans isomer are ob- served in different regions as a double-set of multiple peaks and those of the cis isomer are overlapped as a single-set of multiple peaks (vide infra). The trans isomer is less polar than the cis isomer in thin layer chromatography.
Notably, the reaction of sulfonamide 1i which has a terminal methylene group, 6-membered cyclization product, piperidine 3, was obtained instead of pyrrole (Table 2, entry 9). A similar piperidine formation in the cyclization was also observed by Göttlich in the CuPF 6 -catalyzed intramolecular cyclization of olefinic N-chloroamines, where the rearrangement reaction pathway was proposed for the generation of piperidine deri vatives. 12 To explore the scope of the (CuOTf)2·C6H6 catalyzed reaction, the cyclization of N-5-alkenyl sulfonamides 4 were examined expecting the formation of 2,6-disubstituted piperidines (Table 3) .
Interestingly, when N-benzoyloxysulfonamides 4a and 4b which had a trisubstituted alkene moiety were subjected to the cyclization, pyrrolidines 5a and 5b were obtained as major products in 66% and 47% yields, respectively, whereas the expected piperidines 6a and 6b were isolated as minor products in 12% and 7% yields, respectively (Table 3 , entry 1, 2). The cis isomers of pyrrolidine derivatives cis-5a and cis-5b were obtained preferentially (vide infra). From the terminal vinylic substrates 4c and 4d, only five-membered ring products 5c and 5d were obtained in 61% and 82% yields, respectively. (Table 3 , entry 3, 4). The formation of pyrrolidine derivatives is a strong evidence to prove that copper(I)-catalyzed cyclization proceeds via aminyl radical intermediates. 13 At radical intermediate G, 1,5-hydrogen shift takes place to afford radical H, which is followed by the oxidation with Cu(II) species to give allylic cation intermediate I accompanying with the regeneration of copper(I). The elimination of a proton from intermediate I leads to the formation of C-N bond to yield product 5a (Scheme 2).
Copper(I)-catalyzed radical cyclization of N-alkynyl N-benzoyloxysulfonamides. The above results prompted us to study the radical cyclization of N-benzoyloxysulfonamides 7 having an alkynyl moiety. Under the standard conditions, the radical cyclization reaction of 7a proceeded and pyrrolidine 8a and 2H-pyrrole 8a' were obtained in low yields of 25% and 20%, res- pectively (Scheme 3). When the reaction was performed in the presence of 10 molar amounts of 1,4-cyclohexadiene, 2H-pyrrole 8a' could not be isolated and pyrrolidine 8a was obtained in better yield of 56% (Table 4 , entry 1). Substrate 7b was transformed into pyrrolidine 8b in 33% yield (Table 4 , entry 2). The configuration of 8b was confirmed by X-ray crystal analysis (Figure 2 ) as a Z-isomer. In addition, the cyclizations of 7c and 7d provided pyrrolidines 9c and 9d in 38% and 74% yields, respectively (Table 4 , entry 3, 4).
Conclusion
In summary, (CuOTf)2·C6H6 was found to be an effective catalyst for the cyclization of various N-alkenyl and alkynyl Nbenzoyloxysulfonamides to 2,5-disubstituted pyrrolidines. The cyclization proceeds via sulfonamidoyl radical addition to intramolecular unsaturated bonds or allylic hydrogen abstraction with the radical intermediates.
Experimental Section

1
H NMR spectra were measured on Bruker Avance 300, 400 and a JEOL-AL400 spectrometers in CDCl3 [using CDCl3 (for 1 H, δ = 7.26) as the internal standard].
13 C NMR spectra were measured on Bruker Avance 300, 400 and a JEOL-AL400 spectrometers in CDCl3 [using CDCl3 (for 13 C, δ = 77.00) as the internal standard]. IR spectra were recorded on a Shimadzu IR Prestige-21 FT-IR Spectrometer. High-resolution mass spectra were obtained with a Q-Tof Premier LC HR mass spectrometer. Melting points were uncorrected and were recorded on a Buchi B-54 melting point apparatus. Flash column chromatographs were performed using Silicycle 60 silica gel and distilled eluting solvents. 1,2-Dichloroethane (ClCH2CH2Cl) was dried by passing over a column of activated alumina (A-2, Purify) followed by a column of Q-5 scavenger (Engelhard). Toluene was obtained from an Innovative Technology PS-400-5 Solvent Purification system.
Cyclization of N-benzoyloxysulfonamide (1a). The experimental procedure is shown below as a typical example for the synthesis of 2a (Table 1 , entry 1). To a solution of N-benzoyloxysulfonamide 1a (0.166 g, 0.4 mmol) in 10 mL of 1,2-dichloroethane was added (CuOTf)2·C6H6 (10 mg, 0.02 mmol) at room temperature under nitrogen atmosphere. The mixture was heated to reflux for 1 h. The reaction was quenched with saturated NaHCO3, and the mixture was extracted three times with ethyl acetate and the combined extracts were dried over anhydrous sodium sulfate. The solvent was removed in vacuo, and the cru- C NMR (100 MHz, CDCl3) δ 144. 9, 141.1, 128.4, 128.3, 126.0, 113.3, 64.2, 61.5, 41.2, 35.3, 32.9, 29.5, 28.2, 18.7; FT-IR(neat): 3020, 2399 , 1454 , 1331 , 1215 , 1149 7, 141.5, 128.4, 128.3, 126.0, 112.2, 66.0, 61.5, 38.2, 37.6, 33.0, 30.4, 30.2, 18.8; FT-IR(neat): 3019, 2399 , 1454 , 1337 , 1215 , 1153 , 1049 9, 64.1, 57.3, 41.1, 31.7, 29.4, 20.9, 18.7; FT-IR (neat): 3020, 2974 , 2399 , 1448 , 1377 , 1330 , 1215 , 1147 , 1064 C NMR (100 MHz, CDCl3) δ 144. 8, 112.2, 66.2, 57.4, 37.9, 32.3, 30.2, 22.3, 18.9, FT-IR (neat): 3020, 2972 , 2399 , 1448 , 1377 , 1334 , 1217 , 1153 , 1053 C NMR (100 MHz, CDCl3) δ 144. 9, 144.7, 141.8, 137.9, 132.5, 132.0, 128.9, 128.5, 127.5, 127.3, 112.9, 112.0, 66.6, 64.8, 57.7, 57.4, 31.9, 31.8, 29.8, 29.6, 22.8, 21.0, 18.6, 18.2; FT-IR (neat): 3018, 2873 , 2399 , 1446 , 1336 , 1215 , 1159 , 1107 147.5, 144.2, 144.1, 143.9, 128.7, 128.5, 124.2, 123.8, 113.9, 112.7, 66.9, 65.2, 58.1, 57.9, 32.0, 31.8, 29.9, 29.4, 22.6, 21.5, 18.5, 18.3; FT-IR (neat): 3018, 2875 , 2399 , 1450 , 1336 , 1215 , 1159 , 1037 9, 143.1, 142.6, 138.9, 135.0, 129.5, 129.1, 127.5, 127.3, 112.7, 111.9, 66.6, 64.7, 57.6, 57.3, 31.9, 31.8, 29.8, 29.6, 22.8, 21.5, 21.4, 20.9, 18.6, 18.3; FT-IR (neat): 3196, 2968 , 2378 , 1456 , 1336 , 1115 , 1028 7, 107.1, 48.6, 39.0, 26.4, 18.3, 16.9; FT-IR (neat): 3024, 2931 , 1359 , 1338 , 1261 , 1215 , 1163 , 1001 4, 135.9, 128.4 (overlapped), 125.9, 123.3, 59.6, 57.9, 39.8, 37.1, 32.7, 30.8, 28.6, 26.0, 18.0; FT-IR (neat): 3018, 2931 , 2399 , 1454 , 1328 , 1217 , 1149 6, 134.6, 128.5, 128.3, 126.4, 126.0, 60.7, 58.8, 40.1, 38.5, 32.7, 32.5, 30.1, 25.8, 18.0; FT-IR (neat): 3018, 2935 , 2399 , 1496 , 1454 , 1377 , 1325 , 1215 , 1145 , 1058 5, 141.5, 128.4, 128.3, 125.9, 113.0, 61.4, 59.9, 45.7, 38.6, 35.8, 32.5, 30.2, 29.5, 22.5; FT-IR (neat): 3018, 2939 , 2399 , 1519 , 1336 , 1215 , 1151 , 1045 6, 126.5, 58.8, 56.5, 40.6, 32.5, 32.4, 25.8, 22.8, 17.9; FT-IR (neat): 3020, 2399 , 1446 , 1377 , 1323 , 1215 , 1145 , 1058 1, 136.7, 128.4, 128.3, 125.9, 117.9, 62.8, 59.9, 40.5, 36.6, 32.7, 30.3, 28.4; FT-IR(neat): 3417, 3019, 2380 , 1459 , 1374 , 1210 , 1139 13 C NMR (100 MHz, CDCl3) δ 141. 4, 139.1, 128.4, 128.3, 126.0, 116.1, 62.8, 61.3, 38.6, 38.3, 32.7, 31.6, 30.2; FT-IR(neat): 3447, 3019, 2380 , 1459 , 1380 , 1338 , 1148 1, 117.4, 62.5, 56.0, 40.6, 31.5, 30.1, 22.2; FT-IR (neat): 3020, 2972 , 1463 , 1377 , 1330 , 1215 , 1151 , 1064 141.5, 136.6, 133.4, 130.0, 129.6, 128.6, 128.4, 128.3, 126.3, 125.9, 62.9, 40.3, 37.4, 32.6, 28.7, 27.3, 17.5; FT-IR(neat): 3417, 2927 , 2254 , 1730 , 1452 , 1346 , 1273 , 1151 3, 138.7, 135.6, 133.5, 130.0, 129.65, 129.59, 128.6, 128.3, 126.5, 126.0, 65.4, 41.0, 40.7, 29.0, 27.3, 17.2; FT-IR (neat): 3426, 3055, 2307 , 1728 , 1420 , 1327 , 1265 , 1150 , 1110 4, 128.4, 128.3, 125.9, 81.3, 77.5, 58.9, 51.9, 37.3, 37.0, 32.4, 31.6, 29.4, 3.5; FT-IR(neat): 3393, 2920 , 1602 , 1338 , 1211 , 1151 , 1070 4, 128.4, 128.3, 126.0, 80.0, 78.6, 60.5, 51.0, 41.2, 37.7, 33.4, 32.4, 30.6, 3.6; FT-IR(neat): 3454, 2924 , 1338 , 1149 , 1069 13 C NMR (100 MHz, CDCl3) δ 141. 1, 131.5, 128.7, 128.43, 128.40, 128.3, 125.9, 122.0, 87.3, 85.3, 59.0, 52.2, 37.4, 37.0, 32.4, 31.6, 29.6; FT-IR(neat): 3395, 2928 , 1612 , 1338 , 1211 , 1151 , 1068 6, 128.54, 128.46, 128.34, 128.28, 126.0, 122.4, 88.5, 84.1, 60.7, 51.2, 41.7, 37.7, 33.3, 32.4, 30.7; 
